Breast regimen-specific consent forms

Dear All,

 

I am pleased to inform you that the breast regimen-specific consent forms have been updated with the following:

  • Subcutaneous administration option for regimens containing Trastuzumab  and Pertuzumab.
  • Standard  statement on alcohol to regimens containing Gemcitabine and Paclitaxel.
  • Standard statement indicating the risk of diabetes with SACT treatment, including those where steroids are in the protocol for anti-emetic/allergy.

The forms are available via CRUK website at: www.cruk.org/sact_consent.

Please forward to your colleagues.

Any questions please let me know.

 

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Guy’s and St Thomas’ NHS Foundation Trust

Guy’s Hospital | Great Maze Pond | London | SE1 9RT
SACT regimen-specific consent forms: www.cruk.org/sact consent |

Our values: Put patients first | Take pride in what we do | Respect others | Strive to be the best | Act with integrity

 

Latest News

By BOPA Executive Committee on 10th August 2026

Highlights of CAPhO Conference 2026 Webinar

Participants are invited to participate in the Highlights of CAPhO Conference 2026 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO). Taking place on Wednesday, August 19, 2026 at 08:00 PT,…

Read article
By BOPA Executive Committee on 10th August 2026

BOPA 2026 Executive Committee Election – Its time to cast your vote!

Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.  Summary of nominations: In 2026 we received 9 nominations for 6…

Read article
By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article